Table 2. Crude Incidence Rates for the Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among 93 746 Persons.

Variable	Topical calcineurin inhibitor (n = 7033)	Topical corticosteroid only (n = 73 674)	Unexposed (n = 46 141)
Keratinocyte carcinoma, No.	444	5560	1740
Follow-up time, person-years	47 103	519 262	155 906
Incidence rate (95% CI), 1000 person-years	9.43 (8.55-10.30)	10.71 (10.43-10.99)	11.16 (10.64-11.68)
Basal cell carcinoma, No.	310	3944	1224
Follow-up time, person-years	47 995	527 898	157 733
Incidence rate (95% CI), 1000 person-years	6.46 (5.74-7.18)	7.47 (7.24-7.70)	7.76 (7.33-8.19)
Squamous cell carcinoma, No.	221	2778	774
Follow-up time, person-years	48 855	537 075	159 912
Incidence rate (95% CI), 1000 person-years	4.52 (3.93-5.12)	5.17 (4.98-5.36)	4.84 (4.50-5.18)